187 related articles for article (PubMed ID: 10695817)
41. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
42. Determination of the specificity of CD45 and CD45R monoclonal antibodies through the use of transfected hamster cells producing individual porcine CD45 isoforms.
Schnitzlein WM; Zuckermann FA
Vet Immunol Immunopathol; 1998 Jan; 60(3-4):389-401. PubMed ID: 9589575
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making process.
Arroyo JL; García-Marcos MA; López A; Menéndez P; Tabernero MD; Sánchez-Abarca LI; Avila-Zarza C; San Miguel JF; Orfao A
Transfusion; 2001 Oct; 41(10):1212-6. PubMed ID: 11606818
[TBL] [Abstract][Full Text] [Related]
44. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies.
Ghannadan M; Baghestanian M; Wimazal F; Eisenmenger M; Latal D; Kargül G; Walchshofer S; Sillaber C; Lechner K; Valent P
J Invest Dermatol; 1998 Oct; 111(4):689-95. PubMed ID: 9764855
[TBL] [Abstract][Full Text] [Related]
45. Detection of malignant melanoma with monoclonal antibodies.
Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
[TBL] [Abstract][Full Text] [Related]
46. Shedding of GD2 ganglioside by human neuroblastoma.
Ladisch S; Wu ZL; Feig S; Ulsh L; Schwartz E; Floutsis G; Wiley F; Lenarsky C; Seeger R
Int J Cancer; 1987 Jan; 39(1):73-6. PubMed ID: 3539825
[TBL] [Abstract][Full Text] [Related]
47. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
[TBL] [Abstract][Full Text] [Related]
48. [Significance of application of immunocytochemical detection of GD2 antigen in bone marrow in neuroblastoma patients].
Bolek-Marzec K; Balwierz W; Wieczorek A; Szewczyk K
Przegl Lek; 2010; 67(6):409-12. PubMed ID: 21344771
[TBL] [Abstract][Full Text] [Related]
49. Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection.
Congy-Jolivet N; Drocourt D; Portet S; Tiraby G; Blancher A
J Immunol Methods; 2013 Apr; 390(1-2):41-51. PubMed ID: 23352853
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibody OPD4 detects neoplastic T cells but does not distinguish between CD4 and CD8 neoplastic T cells in paraffin tissue sections.
Chadburn A; Husain S; Knowles DM
Hum Pathol; 1992 Aug; 23(8):940-7. PubMed ID: 1353748
[TBL] [Abstract][Full Text] [Related]
51. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
[TBL] [Abstract][Full Text] [Related]
52. New method for quantitative analysis of GD2 ganglioside in plasma of neuroblastoma patients.
Czaplicki D; Horwacik I; Kowalczyk A; Wieczorek A; Bolek-Marzec K; Balwierz W; Kozik A; Rokita H
Acta Biochim Pol; 2009; 56(3):423-31. PubMed ID: 19724779
[TBL] [Abstract][Full Text] [Related]
53. A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.
Frost JD; Hank JA; Reaman GH; Frierdich S; Seeger RC; Gan J; Anderson PM; Ettinger LJ; Cairo MS; Blazar BR; Krailo MD; Matthay KK; Reisfeld RA; Sondel PM
Cancer; 1997 Jul; 80(2):317-33. PubMed ID: 9217046
[TBL] [Abstract][Full Text] [Related]
54. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
[TBL] [Abstract][Full Text] [Related]
55. Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma.
Panosyan WS; Panosyan DE; Koster J; Panosyan EH
Pediatr Res; 2023 Aug; 94(2):458-461. PubMed ID: 36788290
[TBL] [Abstract][Full Text] [Related]
56. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN
Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727
[TBL] [Abstract][Full Text] [Related]
57. Comparative study of monocyte enumeration by flow cytometry: improved detection by combining monocyte-related antibodies with anti-CD163.
Zarev PV; Davis BH
Lab Hematol; 2004; 10(1):24-31. PubMed ID: 15070214
[TBL] [Abstract][Full Text] [Related]
58. Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2) monoclonal antibody for treatment of neuroblastoma.
Slatnick LR; Jimeno A; Gore L; Macy ME
Drugs Today (Barc); 2021 Nov; 57(11):677-688. PubMed ID: 34821881
[TBL] [Abstract][Full Text] [Related]
59. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Cheung IY; Sahota A; Cheung NK
Cancer; 2004 Nov; 101(10):2303-8. PubMed ID: 15484213
[TBL] [Abstract][Full Text] [Related]
60. Human blood basophils display a unique phenotype including activation linked membrane structures.
Stain C; Stockinger H; Scharf M; Jäger U; Gössinger H; Lechner K; Bettelheim P
Blood; 1987 Dec; 70(6):1872-9. PubMed ID: 3118989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
